{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-100985","form_type":"8-K","ticker":"IXHL","cik":"0001873875","company_name":"Incannex Healthcare Inc.","filed_at":"2025-10-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.937697+00:00","generated_at":"2026-05-17T02:49:12.547463+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Incannex gets 180-day Nasdaq extension to April 20, 2026 for bid price compliance","bullets":["Nasdaq granted Incannex until April 20, 2026 to maintain $1.00 closing bid for 10 consecutive days.","Extension follows Incannex meeting all other listing criteria and providing reverse stock split intent.","CEO notes two Phase 2 clinical data packages delivered in 2025 and strong cash position.","Company will monitor share price and take actions to regain compliance within the extension period."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-100985","json":"https://secwatch.observer/filing/0001213900-25-100985.json","markdown":"https://secwatch.observer/filing/0001213900-25-100985.md","text":"https://secwatch.observer/filing/0001213900-25-100985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873875/000121390025100985/0001213900-25-100985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873875/000121390025100985/ea0262073-8k_incannex.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:49:12.547463+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}